The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Kewalramani Reshma since year 2005.
The trader's CIK number is 1735944.
At the time of the last reporting, Kewalramani Reshma was the EVP and CMO of Vertex Pharmaceuticals Inc / Ma .
(stock ticker symbol VRTX).
See this page for all insider trading activities at Vertex Pharmaceuticals Inc / Ma .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-11-08||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||509||199.00||101,291|
|2019-11-08||VRTX||Vertex Pharmaceuticals Inc / Ma||Option Ex||509||155.57||79,185|
|2019-10-30||VRTX||Vertex Pharmaceuticals Inc / Ma||Option Ex||3,057||155.57||475,577|
|2019-10-30||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||3,057||199.00||608,343|
|2019-10-22||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||638||189.00||120,582|
|2019-05-15||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||241||165.41||39,863|
|2019-02-19||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||1,488||187.50||279,004|
|2018-10-08||VRTX||Vertex Pharmaceuticals Inc / Ma||Sale||2,305||186.95||430,919|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kewalramani Reshma (EVP and CMO of Vertex Pharmaceuticals Inc / Ma at the time of this reporting) see the Securities and Exchange Commission (SEC) website.